Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Vγ2 clonotype frequencies in IL-2 treated cultures.

From: Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells

Clonotypes Ex Vivo IPP IL2
DONOR: ND001 2008 2008 2008
CALW         SR         ELG 34 21 25
CALWE         A         ELG 28 14 34
CALWE         RK   QELG 6 9 <3
CALWEV      RK         LG <3 4 <3
CALWEV               QELG <3 3 <3
CALWE         T      QELG <3 21 <3
CALWE         TE   QELG <3 10 <3
N 158 239 268
DONOR: ND006    
CALWEV               QELG 13 13 <3
CALWE         AK      ELG 9 10 <3
CALWE         A      QELG 6 12 <3
CALWEV      R         ELG 4 4 <3
N 206 287 172
DONOR: ND019    
CALWEV      D         ELG 36 23 <3
CALWE      PQ      QELG 5 7 <3
CALWEV               QELG 8 5 6
CALWEV   R            ELG <3 8 9
CALWE      A         QELG 9 7 18
CALWE      IE      QELG <3 5 <3
N 256 246 242
  1. Vγ2 chains from donor PBMC, IPP-stimulated cell lines, and IL-2 only treated cells were sequenced. Individual Vγ2 clonotypes frequencies for stable clonotypes were calculated as a proportion of total sequences obtained from each donor sample. Any sequences present at a frequency below 3% are under the limits of detection for this assay. The total numbers of sequences analyzed for each sample are listed.